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It is now established that acquired immunity in the mouse (1) and the rat (2) 
to  infection  with  Listeria  monocytogenes  is  cell-mediated.  It  has  been  shown 
(1) for example that normal mice can be adoptively immunized against lethal 
Listeria  challenged  with  splenic  lymphoid  cells,  but  not  with  serum  from 
convalescing donors. It has also been shown (3-5) that the responsible lymphoid 
cells are thymus-derived lymphocytes  (T  cells) as evidenced by their suscep- 
tibility to anti-0 serum and complement. 
The  appearance of these cells in  the  spleen is associated with a  striking in- 
crease in cell division which peaks on  about  the 6th  day of infection  (6).  It is 
also at this time that the host displays maxbnum delayed sensitivity to Listeria 
antigens,  and  its splenic lymphoid  cells  are  most  efficient  at  adoptively im- 
munizing normal  recipients. After  the  6th  day  these  parameters  of  the  anti- 
Lisleria response decay. 
This paper will show  that  by the  6th  day of infection the spleen acquires a 
greatly enlarged population of replicating T  cells, and  that  the cellular medi- 
ators of anti-Lisleria immunity reside within this population. In addition, it will 
provide  evidence  concerning  the  longevity of  these  T  cell mediators  of  anti- 
microbial immunity and the features they have in common with other effector 
cells of this class. 
Materials and Methods 
Mice.--Adult  B6AF1 (C57BL/6)<  A/J)  mice  of  both  sexes were  employed.  Parental 
C57BL/6 and A/J strains were obtained from Jackson Laboratories, Bar Harbor, Maine; as 
were the C3H and AKR strains used for producing anti-0 serum. 
Bacteria.--Lisleria monocytogenes (strains EGD)  was maintained in  a  virulent state  by 
repeated passage  in CD-1  mice (Charles River Breeding  Laboratories, Wilmington,  Mass,). 
Before each experiment it was isolated from a 3 day infected spleen, grown in Trypticase soy 
broth (Baltimore Biological Laboratories, Baltimore, Md.) for 12-15 h, and diluted appropri- 
ately in 0.9% sodium chloride  solution for intravenous injection.  The infecting  dose varied 
between 9 )< 102 and 1.5 X  l0  g. 
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Delayed Sensitivity.--Delayed  skin reactivity was determined at stated times by injecting 
20/zg of Lfsteria antigens in 0.04 ml of phosphate-buffered saline (PBS) 1 into the right-hind 
footpad. Increase in footpad thickness was measured 24 h later with dial calipers, and compared 
with the thickness of the left-hind footpad injected with the same volume of PBS. Listeria 
protein antigens were purified from  dialysed  culture medium by  column  chromotography 
(Ishibashi and Mackaness, unpublished observation). 
Antisera.--The  production of anti-0 C3H  serum was elicited in AKR mice by injecting 
them intravenously and intraperitoneally at 7-day intervals over 5 wk with 107 C3H thymo- 
cytes. Mice were bled from the heart 7 days after the last injection. The antiserum was diluted 
1 : 1 in Dulbecco's PBS and absorbed for 30 mill at 37°C  with AKR thymocytes (108/ml). It 
was then stored in aliquots at --20°C. Evidence that the cytotoxicity of this antiserum can be 
removed by absorption with C3H brain has been published elsewhere (4). 
Rabbit antimouse immunoglobulin serum (anti-Ig) or the Ig fraction of this antiserum, was 
purchased from Miles Laboratories, Inc. Kankakee, Ill., and from Nutritional Biochemicals 
Corp.,  Cleveland, Ohio.  Antiserum from  the first mentioned supplier was accompanied by 
immunoelectrophoretic data which attested its specificity for mouse Ig. Antiserum from the 
latter supplier was shown to be specific for mouse Ig by immunoelectrophoresis against whole 
mouse serum. 
The  IgG  fraction  of  fluoroscein  isothyocyanate-conjugated  rabbit antimouse  immuno- 
globulin serum (FIC anti-Ig) was purchased from Miles Laboratories. It was diluted in PBS 
to  2 mg protein/ml  (520 #g antibody protein/milliliter), absorbed for 30 min at 4°C  with 
108 B6AF1 thymocytes/milliliter, and stored in aliquots at --20°C. 
Immunofluorescence.--The method of Raft  (7)  was used  to determine the numbers of  8- 
positive and Ig-bearing lymphocytes in normal and 6 day-infected spleens. Individual spleens 
were diced finely with a scalpel blade and forced through a 200 mesh stainless steel sieve into 
PBS containing 5% fetal calf serum  (PBS-FCS). The cells were dissociated from clumps by 
repeated pipetting,  and were passed  through six layers of  surgical gauze.  They were  then 
washed  three times by repeated  centrifugation  (350 g)  and resuspension in  PBS-FCS  and 
diluted appropriately for counting in a hemacytometer and for testing viability by dye exclu- 
sion. All of the above procedures were performed at 4°C. Viability varied between 87% and 
95%. 
The immunofluorescent technique relied on the knowledge (7) that FIC anti-Ig alone stains 
Ig-bearing B lymphocytes, whereas after incubation with anti-0 serum it also stains P-positive 
T  lymphocytes.  The  former  display  mainly  "capped  fluorescence"  and  the  latter  diffuse 
"ringed fluorescence". 2 X  107 spleen cells were suspended in 0.5 ml of either 1 : 1 anti-0 serum, 
or 1 : 1 normal AKR serum at 4°C for 20 rain. They were then washed two times with 5 ml of 
PBS-FCS and resuspended in 0.5 ml of 1:5 FIC anti-Ig for 15 rain at 4°C  and for 5 rain at 
23°C.  This was followed by two washes in PBS-FCS at 4°C. The cells were then resuspended 
in 0.25 ml of PBS-FCS and examined under ultraviolet light with a Zeiss fluorescence micro- 
scope (Carl Zeiss, Inc., New York) fitted with a dark field condenser and an Osram HBO-200 
watt high pressure mercury lamp. Zeiss exitation filter BG12, and barrier filters nos. 53 and 44 
were employed. The percent fluorescence cells per 300 cells was determined for each sample. 
The specificity of  the above reagents was  established by the findings that FIC  anti-Ig 
either alone, or after incubation with normal AKR serum did not stain either C3H on B6AF1 
thymocytes, but stained 100% C3H and B6AF1 thymocytes after  incubation in anti-0 C3H 
serum. 
Transfer of Anti-Listeria  Immunity.--Spleen  cell  suspensions from  normal  and  6  day- 
infected donors were prepared as described previously (1). Donors were injected subcutaneously 
with 5,000 U of potassium penicillin G, and given drinking water containing 0.5 mg of ampi- 
1Abbreviations used in  this paper: FIC  anti-lg,  fluoroscein  isothyocyanate-conjugated 
rabbit antimouse immunoglobulin serum;  PBS,  phosphate-buffered saline; PBS-FCS,  PBS 
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cillin/milliliter 24 h  before harvesting their spleen cells.  This reduced the number of Listerla 
in donor spleens by 100-fold  at the time of cell transfer. Thus, after processing, the number of 
Listeria infused with "immune" spleen cells was never more than 2  -- 3  X  102. Normal re- 
cipient mice were challenged intravenously with 10 LDs0  Listeria (4.5  X  104) and infused 2 
h later with either 1.5  X  l0 s normal or immune spleen cells.  The organism was enumerated 
at stated  times in recipients' livers and spleens by plating 10-fold  serial dilutions of organ 
homogenates on Trypticase soy agar. 
The susceptibility of the cellular mediators of anti-Listeria immunity to anti-O serum was 
tested by suspending spleen cells at 108/ml in 1:6 anti-0 serum for 20 rain at either 37°C  or 
4°C for 20 rain. This was followed by a 20 rain incubation at 37°C  in the same volume of 1:5 
agarose-absorbed (8) guinea pig serum. After two washes in 50 ml of PBS the cells were sus- 
pended at an appropriate concentration for intravenous injection. Control cells were treated 
the same way except that they were incubated in normal AKR serum instead of anti-# serum. 
The effect of a  1:5 dilution (520 #g antibody protein/milliliter) of anti-Ig serum on the 
cellular mediators of immunity was tested in the same way.  Control cells were incubated in 
the same volume of heat-inactivated normal rabbit serum. There is convincing evidence (9) 
that anti-Ig serum plus complement is cytotoxic for Ig-bearing B cells in vitro. 
Estimating Spleen Cell Proliferatlon.--In vivo spleen cell proliferation was estimated  by 
pulsing mice intravenously with 20/zCi  tritiated thymidine  ([3H]TdR)  of  specific activity 
3 Ci/mM (New England Nuclear, Boston, Mass.). 30 min later the spleens were weighed and 
known weights extracted with trichloroacetic acid  (TCA)  (10).  [~H]DNA  was  counted  by 
liquid scintillation spectrometry as described previously (10). 
DNA synthesis by spleen cells was measured in vitro by incubating 20 X  106 cells for 30 
rain at 37°C  in 2.5 ml of Eagle's minimal essential medium containing 5% FCS and 0.5 #Ci 
[3H]TdR per milliliter. After two washes in i0 ml PBS they were resuspended in 5 ml of cold 
(4°C) TCA for 1 h, washed in a further 5 ml cold TCA and then extracted for 1 h in hot (90°C) 
TCA. [SH]DNA in the extract was counted as above. 
The effect of anti-~ serum and anti-Ig serum on [3H]TdR incorporation in vitro was tested 
by suspending 20 X  106 spleen cells in 0.5 ml of a  1:5 dilution of either antiserum for 15 rain 
at 4°C, and then in 0.5 ml of 1:5 agarose absorbed guinea pig serum for 30 rain at 37°C.  The 
guinea pig serum contained 200 U/ml of DNAase (Sigma Chemical Company, St. Louis, Mo.). 
The cells were then incubated for 30 mln in [SH]TdR-containing medium as above and ex- 
tracted for DNA. 
Vinblastine SulJ'ate.--This was obtained from Eli Lilly and Co., Indianapolis, Ind. It was 
dissolved in PBS and administered in a dose of 100 #g subcutaneously. This dose should have 
been active in destroying mitosing cells for a period of approximately 15 h  (11). Its effect on 
the mediators of immunity was investigated by injecting it into prospective donors on day 6 
of infection and preparing spleen cell suspensions 15 h later. 
RESULTS 
Kinetics of the Production of the Cellular Mediators of Immunity in the Spleen 
in Relation to Increases in DNA Synthesis, Cellularity, and Delayed Sensitivity.- 
Fig.  1  shows  the time-course of the production of the cellular mediators of im- 
munity  in the spleens of mice given an intravenous immunizing dose of Lisleria 
(1.3  X  103).  The  production  of  these  cells  is  shown  in  relation  to  changes  in 
total DNA  synthesis,  spleen weight,  and numbers  of nucleated  cells.  The pro- 
duction  of  mediator  cells  was  measured  by  determining  the  capacity  of  one 
organ  equivalent  of  spleen  cells,  taken  at  progressive  stages  of  infection,  to 
protect  normal  recipients  against  a  standard  lethal Listeria  challenge  (4.5  -- ROBERT  J.  NORTH  345 
4.7  X  104). Adoptive immunity (log protection)  is expressed  as the log differ- 
ence between the number of Listeria in the spleens of recipients of "immune" 
spleen cells and normal spleen cells after 48 h of the challenge infection. Assum- 
ing  that  the  level  of protection  transferred  was  a  function  of the  number  of 
cellular  mediators  in  the  spleen,  rather  than  to  a  change in  their  individual 
efficiency, the results  show that cellular mediators  were first produced in sig- 
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FIG. 1.  Parameters  of the response to an intravenous  immunizing infection with Listeria 
showing production  of cellular mediators  of immunity in  the  spleen at progressive times 
(histograph)  in relation  to changes in spleen weight, spleen cellularity,  and cell division as 
measured by [3HITdR incorporation into total spleen DNA. The relative number of mediator 
cells in the spleen was determined by measuring the capacity (log protection)  of one organ 
equivalent  of spleen cells harvested  at the times indicated  to adoptively  immunize normal 
recipients against a standard  challenge infection. Means of five mice per time point. 
nificant numbers in the spleen between days 2 and 4 of infection. They rapidly 
increased in numbers to peak on day 6, were sustained in numbers large enough 
to give maximum protection until day 10,  and then progressively decreased in 
number until  day 20 when the spleen no longer contained enough to transfer 
significant immunity. The total numbers of spleen cells giving the above levels 
of adoptive immunity are represented by the curve for spleen cellularity (Fig. 1). 
The production of the cellular mediators of immunity was obviously associated 
with  a  striking  increase  in  spleen  cellularity  and  a  corresponding increase  in 
spleen  weight.  Clearly,  the  splenornegaly  of  infection  is  due  in  part  to  an 
accumulation of immune mediator cells. 
That the production of mediator cells depended on increased cell division is 346  CELLULAR  MEDIATORS  OF  ANTI-LISTERIA  IMMUNITY 
indicated by the curve for [aHJTdR incorporation into total  spleen DNA  (Fig. 
1).  It can be seen  that  the increase in the number of mediator cells coincided 
with a major increase in DNA synthesis. The progressive loss of mediator cells, 
on the other hand, closely followed a decrease in DNA synthesis. It is apparent, 
therefore,  that  the curve for DNA synthesis represents the time-course of the 
production of the mediators of immunity. 
The  above results indicate  that maximum production  of cellular mediators 
was sustained between days 6 and 10 of infection. It seemed possible, however, 
M 
3°C  ~  1,2 
; '"~'.,~"  Ik  DTH 
,:  "-,,lily  !~  ~',,' II  %  ~o 
•  LOG LISTERIA/~,~| I 
•  ~  w  /  ',e~  %. 
.,  lli,,,. 
i  /  I1~  E 
=,-, 
i_- z 
,.o  3-,.4 
o.,/o  ",.  !o., 
I.I  I.I  o  •  ,  .  •  ~.o 
2  4  6  1o  ~2  1~  16  18  20 
DAYS 
];'IG. 2.  The protective capacity' (log protection, histograph)  of one-half organ equivalent of 
spleen cells at progressive times of infection to adoptively immunize normal recipients against 
a lethal challenge infection. This method,  by way of titration, gives a more correct measure- 
ment of changes in the relative content of cellular mediators in the spleen. It shows that peak 
production was not sustained after day 6. Included are concurrent  measurements  of delayed 
sensitivity (DTH) to Listerfa antigens,  and the growth curve of Lisleria in the spleen in mice 
of the same age and sex. Means of five mice per time point. 
that a  reduction in their number during this time was not detected because of 
the presence of more than  enough of them in the spleen to transfer maximum 
protection. This possibility was  tested by reducing the number  of spleen cells 
infused to a half spleen equivalent. The results in Fig. 2 show that peak produc- 
tion of mediator cells was reached on day 6, and decreased progressively there- 
after. These data, therefore, represent a  more accurate estimate of the relative 
numbers  of mediator cells at progressive stages of infection.  Fig. 2 also shows 
concurrent  measurements  of  the  growth  of  Lisleria  in  the  spleen,  and  the 
development of delayed sensitivity to Listeria antigens in mice of the same sex 
and  age.  It  can  be  seen  that  the  level  of delayed skin  reactivity at  any one 
time was proportional to the number of cellular mediators in the spleen. This ROBERT J.  NORTH  347 
indicates that the number of mediator cells present in blood was determined by 
the level of their production in the  spleen. Again, it can  be  seen  that Listeria 
grew  unrestrictedly in  the  spleen for 48 h,  and  was  not  subjected  to  any in- 
hibitory influence until  the production  of the cellular mediators of immunity 
was  underway,  and  the host had  developed a  capacity to  express a  delayed- 
type sensitivity reaction against the organism. 
Cellular  Composition of the Spleen at Peak Response.--A comparison between 
the  cellular  composition  of  normal  and  6  day-infected  spleens  is  shown  in 
TABLE I 
Changes in Cellular Composition of the Spleen Associated with Production and Loss of 
Listeria-Committed Lymphocytes 
Group* 
6 day- 
infected$ 
Controls 
Spleen 
wt 
mg 
316X 
-I-23.5 
91.2 
4-3.6 
129 
±15 
No. cells  In vivo 
per  [3H]TdR 
incorp, cpm  spleen  I  X 10-~  X 10-6 
I 
267  318.3 
4-17  4-43 
92.7 
4-9 
Cells  ]  stained  ]  Cells 
anti-O+ [  stained 
anti-Ig  anti-Ig 
61.5  28.4 
-4-2.5  4-0.9 
63.4 
4-9.7 
36.1 
4-3.5 
0-positive  No.  Ig-bea 
_ cells  I  xcell~10 
3 °1 
i  4-1.7 
27.3 
4-6.22 
No. 
[g-bearing 
cells 
X  10-6 
75.82 
4-4.5 
46.57 
4-8.2 
~'~o. 
0-positive 
cells 
X106 
88.37 
4-8.4 
35.21 
-4-6.4 
15 day- 
infected§ 
162  169 
±6.07]  4-12 
120  55.64  25.5  30.13  43.3  54.6 
±15.3  4-5.67  4-1.55  4-5.74  4-4.6  4-9.4 
* Means 4-SE of four mice per group. 
$ Infection resulted in 6 days in (a) 3.47-fold increase in spleen wt; (b) 3.4-fold increase in 
[3H]TdR incorporation; (c) 2.07 times more nucleated cells; (d)  1.62 times more Ig-bearing 
cells; (e) 2.51 times more 0-positive cells. 
§ By day 15 o[ infection the cellular composition of the spleen was returning to normal. 
Table I. An infection-induced increase in cellularity was evidenced both by an 
increase in spleen weight and  an  increase in  the yield of nucleated  cells. Im- 
munofluorescence showed that increased cellularity was associated with a major 
increase in the total numbers of Ig-bearing plus 0-positive cells. Thus, the total 
number  of cells which  stained with  FIC  anti-Ig after  treatment  with normal 
AKR serum  (Ig-bearing B  cells) increased 1.5  times. Most of these  (80-90%) 
showed  capped fluorescence  while  the  remainder  showed  either  sharp  ringed 
or  speckled fluorescence.  Incubation  with  anti-0  serum  greatly increased  the 
total number of cells which stained with FIC anti-lg. This was caused by the 
presence of 0-positive T  cells, which  showed diffuse ringed fluorescence of the 
type displayed by B6AF1 thymocytes exposed to the same reagents.  By sub- 
traction, it can be seen that Listeria infection resulted in a  2.5-fold increase in 348  CELLULAR  MEDIATORS  O~"  ANTI-LISTERIA  IMMUNITY 
the total number of 0-positive cells in the spleen: in this experiment an increase 
of 53 X  106 T  cells. 
The percentages of Ig-bearing and 0-positive cells found in normal spleens in 
this  study  are  in  general  agreement  with  the  published  findings  of Raft  (7); 
so  were  the  staining  characteristics  of these  cells.  It will  be  noted,  however, 
that an increase in their total numbers in response to Lisleria infection was not 
necessarily  reflected  by an increase  in  their proportions.  It will also be noted 
that only about 60% of the total spleen cell population shown in Table I  was 
Ig-bearing and  0-positive  according  to immunofluorescence.  This  was  signifi- 
TABLE II 
Changes in the Cellular Composition of the Spleen Associated with Peak Production of 
Listeria-Committed Lymphocytes* 
No. cells  In vivo  Cells  Ceils  No.  No. 
Group  Spleen  per  [~H]TdR  stained  0 positive  Ig-bearing  0-positive 
wt  spleen  incorp,  anti-O +  stained  cells  cells  cells 
M  10-~  cpm X  10  .3  anti-Ig  anti-Ig  X  10  -~  X  i0-~ 
Exp.  1" 
6 day- 
infected 
mg  %  % 
300  215  286.5  90  33  57  71  123 
Controls  99  115  82.7  88.2  38.9  49.3  44.7  56.7 
Exp. 2* 
6 day- 
infected 
378  319  298.3  93.68  55.11  38.57  175.8  123 
Controls  106  101  81.2  82.69  48.0  34.69  48.5  35 
These results essentially confirm those shown by Table I. 
* Results obtained with pooled spleen cells of five mice per group. 
cantly lower than  the  total  percentages  of stained  cells in subsequent  experi- 
ments.  Table  II  shows  the  results  of pooling  cells  from five  spleens  in  two 
similar experiments.  It shows that about 90% of the spleen cells were stained. 
The reason for these differences is not known. It may have been caused by the 
fact  that  the  mice represented  by Table  I  were 3  wk younger than  those  of 
Table II. Alternatively, there may have been more cell death during incubation 
with specific reagents in the first experiment. 
The increased  numbers  of 0-positive and Ig-bearing cells  in  the  spleen  was 
short-lived after peak response. This is shown by Table I  where it can be seen 
that by day 15 the numbers of 0-positive and Ig-bearing cells were approaching 
control  values.  By  this  time  the  numbers  of cellular  mediators  in  the  spleen 
were also greatly reduced  (compare Figs.  1 and 2). 
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Spleens were Synthesizing  DNA .---The foregoing experiments showed that the 
infection-induced increase in the numbers of 0-positive and Ig-bearing cells in 
the spleen was associated with a major increase in [3H]TdR incorporation into 
total spleen DNA. The following results indicate that part of this increase in 
[3H]TdR incorporation can be accounted for by an increase in the total numbers 
of 0-positive and Ig-bearing cells in DNA synthesis. Table III shows the effect 
of anti-0 serum and anti-Ig serum on the capacity of spleen cells from normal 
TABLE III 
Suppression  of In Vitro [3H]TdR Incorporation by Anti-O Serum  and Anti-Ig Serum 
6 day- 
infected 
(n  =  4) 
Controls 
(n  =  4) 
[3H]TdR incorporation  mean cpm/20  X  106  cells  :kSE  Mean percent inhibition 4-SE 
Normal  Anti-0 serum  Anti-Ig serum  Anti-0 serum  Anti-Ig serum  AKR serum 
20.44  ±  3.4  28.53 ±  2.7  7,745 
-4-269 
1,103 
.4-97 
6,162  ±  337 
825  ±  62.5 
5,535  ±  124.5 
848  -4- 66.5  25.20  4-  1.95  23.12  4-  1.05 
and 6 day-infected mice to incorporate [3H]TdR in vitro. It can be seen that 
immune spleen cells incorporated  over seven times more [~H]TdR into DNA 
than the same number of normal spleen cells.  Furthermore, pretreatment with 
either anti-0 serum or anti-Ig serum caused a significant suppression of [~H]TdR 
incorporation both in normal and immune spleen cells,  the percent inhibition 
being roughly the  same.  In  terms of total  inhibition,  however,  anti-0 serum 
caused over six times,  and anti-Ig serum over eight times, more inhibition in 
imnmne than in normal spleen cells.  By referring to Table I, (results of a con- 
current experiment with mice of the same age and sex) it will be seen that the 
proportion  of 0-positive cells  was  roughly  the  same in  normal  and  immune 
spleen  cell populations,  and  that  there was even a  smaller proportion  of Ig- 
bearing cells in the immune spleen cell  population.  It follows, therefore,  that 
the higher total inhibition of in vitro [3H]TdR incorporation in immune spleen 
cells  must  have  resulted  from  the  action  of  the  antisera  either  on  a  larger 
proportion of 0-positive and Ig-bearing cells in DNA synthesis,  or on similar 
proportions of replicating cells with faster rates of DNA synthesis. The former 
possibility seems more likely, because it is difficult to conceive a six- to eightfold 
difference in the rate of DNA synthesis by cells of the same lineage, particu- 
larly since the lymphocytes which divide in the normal spleen like those in the 
immune spleen must be considered as blast cells.  If equal rates of DNA syn- 
thesis  can  be  assumed,  and  if  the  anti-0  and  anti-Ig serum performed  with 
equal  efficiency  against  replicating  lymphocytes  from  normal  and  immune 350  CELLULAR  MEDIATORS  O:F  ANTI-LISTERIA  IMMUNITY 
spleens,  the results indicate that on a  cell for cell basis 6 day-infected spleen 
cells  contained  over six  times  more  0-positive  and  about  eight  times  more 
Ig-bearing  cells  in  I)NA  synthesis  than  normal.  Furthermore,  because  the 
spleens of 6 day-infected mice contained a  total of 2.5  times more 0-positive 
and  1.5  times more Ig-bearing cells than normal spleens, it follows that they 
must have contained a  total of about 14 times more 0-positive and  14 times 
more Ig-bearing  cells  in  DNA  synthesis.  Similar results  were obtained  with 
pooled spleen of five mice in three separate experiments. Even if these results 
are considered approximations, they leave no doubt that the anti-Listeria re- 
sponse results in a striking increase in the total numbers of replicating 0-positive 
and Ig-bearing lymphocytes in the spleen. 
Evidence that the Mediators of A nti-Listeria Immunity are Dividing T Cells.--It 
is  the  acquired population  of replicating T  cells,  rather  than  B  cells,  which 
contains the cellular mediators of anti-Listeria immunity. This is shown in Fig. 3 
where it can be seen that treatment of immune spleen cells with anti-0 serum 
and complement completely eliminated their capacity to adoptively immunize 
normal recipients against lethal challenge. In contrast, treatment with anti-Ig 
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FIG. 3.  Evidence that the cellular mediators of anti-Lislerla immunity are thymus-derived 
lymphocytes (T cells). The capacity of spleen cells from 6 day-infected donors to adoptively 
immunize normal recipients was completely eliminated  by incubating the spleen cells with 
anti-0 serum and complement. In contrast, incubation with anti-Ig serum and  complement 
was completely without effect. Means of five mice per time point. ROBERT  J.  NORTH  351 
serum  and  complement  had  no  effect  on  the  protective  capacity of immune 
spleen cells. The same result was obtained whether the spleen cells were treated 
with the antisera at 4°C or at 37°C. 
Evidence that the mediators of anti-Listeria  immunity are rapidly dividing 
cells can be seen in Fig. 4  which shows the effect of a  15 h  pulse of the anti- 
mitotic drug,  vinblastine,  on the  capacity of spleen  cells from 6  day-infected 
donors  to  protect  normal  recipients  against  challenge  infection.  Even  three 
organ  equivalents  (4  X  10  ~ cells  in  two  doses given 30 rain  apart)  of spleen 
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FIG. 4. The elimination of the cellular mediators of immunity from the spleens of 6 day- 
infected (peak response) donors by a 15 h pulse of the antimitotic drug vinblastine. The graph 
shows the capacity of 1 and of 3 organ equivalents of spleen cells from these mice to protect 
recipients against lethal challenge. Not even 3 organ equivalents of spleen cells could protect 
normal  recipients. This indicates  that most of the T  cell mediators  of immunity were de- 
stroyed as a result of entering division during the pulse of vinblastine. 
ceils from vinblastine-treated  donors failed to protect normal recipients.  Most 
of the mediator T  cells must have entered  mitosis and been destroyed during 
the 15 h pulse of vinblastine. 
DISCUSSION 
Assuming that the immunofluorescence technique  employed gives a  reason- 
able  approximation  of the  number  of 0-positive and  Ig-bearing lymphocytes, 
this study leaves no doubt that the production of the mediators of anti-Listeria 
immunity is  associated  with  a  striking  increase  in  the  production  of T  cells 
and B  cells in the spleen.  Furthermore,  the demonstration that the mediators 
of immunity are eliminated by treatment with anti-0 serum, but not by treat- 352  CELLULAR  MEDIATORS  OF  ANTI-LISTEt~IA  IMMUNITY 
ment  with  anti-Ig serum,  means  that  they are  part  of the  expanded T  cell 
population, not the expanded B cell population. It seems likely from the nega- 
tive result with anti-Ig serum, that mediator T cells have either very few, or no 
immunoglobulin determinants exposed on their plasma membranes. 
The elimination of mediator T cells from donor spleens at peak response by a 
15 h pulse of vinblastine, indicates that the majority of them must enter mitosis 
within this time span. This agrees with published findings on the vinblastine 
sensitivity  of  the  mediators  of anti-Listeria  immunity in  the  rat  (12).  The 
conclusion that  they are rapidly dividing cells is reinforced by the additional 
finding that an increase in their numbers in the spleen is associated with a major 
increase in DNA synthesis. Furthermore, a significant proportion of the higher 
than normal rate of DNA synthesis in vitro by spleen cells  from immunized 
animals could be suppressed by anti-0 serum and complement. This allows the 
calculation that a large increase in the total number of T  cells in the spleen at 
peak response is associated with a much larger increase in the number of them 
in DNA synthesis. 
A progressive loss  of mediator cells  from the spleen, on the other hand,  is 
closely associated with a progressive decrease in the total number of T cells and 
also with a progressive decrease in DNA synthesis. These data indicate that an 
effective population of mediator T  cells  can only be sustained  by rapid  self- 
replication. It is apparent that when the stimulus for their division declines, 
they have only a relatively short life-span in the spleen. Furthermore, the find- 
ing that a progressive loss  of cellular mediators from the spleen is associated 
with  a  corresponding and  progressive decrease in  delayed skin  reactivity to 
Listeria antigens indicates that these cells also have a short life-span in blood. 
This can only mean that their effective existence after their formation is quite 
a  brief one. It seems reasonable to suggest at this point that the progressive 
decay of the immune response after day 6 of infection probably results from the 
rapid elimination of the infecting organism from the tissues and the consequent 
decline in the intensity of antigenic stimulation (Fig. 2). 
It should be realized that the adoptive transfer experiments described here 
represent an attempt to transfer the bulk of an ongoing immune response to 
normal recipients. The onset of adoptive immunity is rapid, and depends on the 
activation of recipient macrophages by a large number of infused mediator T 
cells (1). It is obvious from the results of this study (Figs.  1 and 2)  that  the 
level  of  macrophage  activation  developed  by  recipients  of  immune  spleen 
cells was directly proportional to the number of mediator T cells infused. These 
experiments did not detect the presence of a  significant number of "memory 
cells" in donor spleens after the conclusion of the immune response. Presum- 
ably, if such cells exist, they are not present in sufficient numbers or an ap- 
propriate physiological condition to protect recipients against a moderate chal- 
lenge infection. 
The relation of the T  cell mediators of anti-Listeria immunity to other types ROBERT  J.  NORTH  353 
of T cells deserves comment. It was shown previously (6) that the accumulation 
of Listeria-sensitized T  cells in the spleen is associated with increased numbers 
of rapidly replicating pyroninophilic cells in the red pulp. The white pulp, in 
contrast, does not appear to undergo change. It was also shown (6) that treat- 
ment with cortisone acetate greatly depletes the spleen of Listeria-committed T 
cells,  and at the same time greatly reduces the number of replicating cells in 
the red pulp, but not the white pulp. These observations indicate that Listeria- 
committed T  cells are not present in large numbers in the so-called thymus- 
dependent regions of the spleen: the arteriolar lymphatic sheaths. It is apparent, 
therefore, that most of them do not accompany the recirculating lymphocytes 
which  include  the  long-lived,  cortisone-resistant,  immunocompetent T  cells 
which initiate allograft immunity (13, 14). This conclusion is supported by the 
published finding (2)  that the mediators of anti-Listeria  immunity in the rat 
do not move freely from blood to central lymph. 
The T  cell-mediators of anti-Listeria immunity do appear to resemble, how- 
ever, the activated T  cells which effect allograft immunity, particularly with 
respect to the time-course of their production and their longevity. It has been 
shown both in the mouse (15) and the rat (16), for instance, that intraperitoneal 
injection of allogeneic cells results in the production in the spleen of lympho- 
cytes which are specifically cytotoxic for the allogeneic cells in vitro. Cytotoxic 
lymphocytes are first present in significant numbers in the spleen at about day 4 
after immunization, reach peak numbers between about days 5 and 8 and then 
progressively disappear. They cannot be detected in the spleen in significant 
numbers 2-3 wk after peak production. It seems highly likely, therefore, that 
the mediators of anti-Listeria immunity and the effectors of allograft immunity 
are the same type of activated T cells, i.e., rapidly dividing and short-lived. It 
should also be mentioned in this connection that the cellular mediators of anti- 
Listeria immunity in the rat (17) and the mouse (North, unpublished observa- 
tion) can be concentrated in sterile inflammatory exudates, as can the sensitized 
lymphocytes which participate in the effector mechanisms of other examples of 
cell-mediated immunity (see ref. 18). 
The  significance of the increased production and  accumulation of rapidly 
dividing Ig-bearing B cells in the spleen during Listeria infection is not known. 
The published findings that primary infections with Listeria need not result in 
the production of detectable circulating agglutinins (19),  and the knowledge 
(North, unpublished observation) that antibodies to protein antigens of Listeria 
could not be detected in serum during primary infection by the passive hemag- 
glutination technique is tentative evidence that the increased production of B 
cells is not associated with the production of specific humoral antibody. It is 
possible that their production results from the action of mitogenic factors re- 
leased by replicating T  cells, as has been shown to occur in vitro when T  cells 
are activated by phytomitogens (20). It is also possible that the newly formed 
B  cell  population may represent  potential  antibody-forming cells  which  are 
suppressed in a response geared to the production of activated T  cells. 354  CELLULAR MEDIATORS O1  ~ .~'qTI-LI,  SI"RRIA  IMIVIUNITY 
SUMMARY 
An intravenous immunizing infection with the facultative, intracellular para- 
site, Listeria monocytogenes results in the production in the spleen of a popula- 
tion  of  immunologically-committed  lymphocytes  which  can  adoptively  im- 
munize  normal  recipients  against  a  lethal  challenge  infection.  These  celhflar 
mediators of immunity are first produced in the spleen between days 2 and 4 of 
infection and reach peak production on day 6. Their production then progres- 
sively  decreases  until  about  day  20  when  their  presence  can  no  longer  be 
detected. 
Increased production of cellular mediators is coincident with major increases 
in cell division, cellularity, and spleen weight. Decreased production of cellular 
mediators,  on  the  other  hand,  is  associated  with  decreases  in  cell  division, 
cellularity, and spleen weight. Again, the level of delayed sensitivity to Lislerie 
antigens expressed by the host at any one time is proportional to the number 
of cellular mediators in the spleen. 
increased production of cellular mediators is also associated with major in- 
creases in the total numbers of replicating T cells and B cells in the spleen. That 
the cellular mediators of immunity are part of the replicating T cell population, 
rather than the B cell population, is evidenced by their susceptibility to anti-0 
serum and by their resistance to anti-Ig serum. Furthermore, they can be com- 
pletely eliminated  from the  spleen  by a  brief pulse  of  the  antimitotic  drug, 
vinblastine.  This  study  allows  the  conclusion  that  the  cellular  mediators  of 
anti-Lislerie immunity belong to an expanded population of rapidly dividing, 
short-lived T  cells. It is suggested that they have the same properties as the T 
cell effectors of allograft immunity. 
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